510(k) Report

FDA applicant

Arrow International, Inc. (Subsidiary of Telelflex Inc.)

Reading, PA1 decision2017–20171 recall

FDA records 1 decision for Arrow International, Inc. (Subsidiary of Telelflex Inc.) (Reading, PA) in 2017: 1 510(k) clearance. All are in product code DQY (Catheter, Percutaneous). Its devices cite 1 predicate, 0 of them its own earlier devices. 1 recall is linked to its devices, 1 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Arrow International, Inc. (Subsidiary of Telelflex Inc.)’s devices, and how often a recall has named them.

FDA decisions per year

1in 2017

2017: 1
2017high 1 (2017) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

1in 2026

2026 (partial year): 1, 1 Class I
2017high 1 (2026) · low 0 (2017)2026

Class I Class II/III not classified

FIG. 1 — Arrow International, Inc. (Subsidiary of Telelflex Inc.) by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Arrow International, Inc. (Subsidiary…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Arrow”

FDA records each applicant name separately; these may or may not be the same firm.